On Wednesday, U.S. Senators Catherine Cortez Masto (D-Nev.), Amy Klobuchar (D-Minn.), and Peter Welch (D- Vt.) introduced the ...

At least six organizations that claim to champion patient rights have deep financial and operational ties to Big Pharma and ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times as ...

The Most Favored Nation order is unlikely to deliver broad, sustained savings without triggering legal challenges, ...

The president announced last week that his administration would be instituting a “most favored nation” policy that would peg ...

HHS is taking “immediate steps” to implement President Donald Trump’s executive order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients — a key initiative aimed at ...

The U.S. Department of Health and Human Services said on Tuesday it would set drug prices pegged to the lowest level paid by ...

The Department of Health and Human Services today announced it has identified specific pricing targets for pharmaceutical ...

Following President Trump's Most Favored Nation executive order, HHS and CMS have released the target price for pharmaceutical manufacturers to meet.

According to the timeline in the May 12 executive order, prescription drug price reductions would not happen "almost ...

The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U.S. price for Keytruda, a cancer treatment, is $191,000 a year; in Japan, i ...